GERMANTOWN, Md.--(BUSINESS WIRE)--Intrexon Corporation, a privately held synthetic biology company, today announced the appointment of Mark F. Kubik, MBA, as Vice President of Business Development for the company’s Maryland-based, Human Therapeutics Division.
